Evidence map›Paper›PMID 36290100›Full record

ArticleAntibiotics (Basel, Switzerland)2022

An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational

Thomas R Laws, Kay B Barnes, Dominic C Jenner, Alejandro Núñez, Mark I Richards, Joanne E Thwaite, Andreas Vente, David Rushton, Michelle Nelson, Sarah V Harding

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Thomas R LawsDefence Science and Technology Laboratory, Porton Down, Salisbury SP4 0JQ, UK.ORCID 0000-0002-0142-9162
Kay B BarnesDefence Science and Technology Laboratory, Porton Down, Salisbury SP4 0JQ, UK.
Dominic C JennerDefence Science and Technology Laboratory, Porton Down, Salisbury SP4 0JQ, UK.
Alejandro NúñezAnimal and Plant Health Agency, Weybridge KT15 3NB, Surrey, UK.ORCID 0000-0001-5926-7541
Mark I RichardsDefence Science and Technology Laboratory, Porton Down, Salisbury SP4 0JQ, UK.
Joanne E ThwaiteDefence Science and Technology Laboratory, Porton Down, Salisbury SP4 0JQ, UK.
Andreas VenteMerLion Pharmaceuticals, 13125 Berlin, Germany.
David RushtonDefence Science and Technology Laboratory, Porton Down, Salisbury SP4 0JQ, UK.
Michelle NelsonDefence Science and Technology Laboratory, Porton Down, Salisbury SP4 0JQ, UK.
Sarah V HardingDefence Science and Technology Laboratory, Porton Down, Salisbury SP4 0JQ, UK.
Defence Science and Technology Laboratory · GBAnimal and Plant Health Agency · GBMerLion Pharma (Germany) · DE

Funding

Defense Threat Reduction Agency HDTRA1-12-D-0003 0019
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibioticBurkholderia pseudomalleico-trimoxazoleeosinfinafloxacinrelapse

Identifiers

PMID36290100
PMCPMC9598772
OpenAlexW4306938581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.